Welcome to

NCC Profile

icon

About Us

Board of Director

Vision

A Leading, Innovative & Specialized Medical Centre

Mission

 To make a meaningful difference through personalized, excellent & quality healthcare services that are safe, efficient & people-centered

 

Value

Working Together
Empathy
Compassion
Attitude - "Can do"
Respect
Ethical

Event

History

A. Oncology Services

  1. Adjuvant Chemotherapy
  2. Neoadjuvant Chemotherapy
  3. Palliative Chemotherapy
  4. Targeted Therapy with oral drugs and monoclonal antibodies
  5. Palliative Pain Control
  6. Immunotherapy

B. Radiation Oncology

  1. Radiotherapy
  2. Palliative Radiotherapy
  3. Stereotactic Radiosurgery
  4. Stereotactic Body Radiotherapy
  5. Brachytherapy

C. Nuclear Medicine

  1. PET (Positron Emission Tomography) / CT-scan
  2. SPECT scan (Single Photon Emission Computed Tomography)
  3. Radio-iodine therapy for thyroid cancer

D. Early Detection and Cancer Prevention

  1. Clinical consultation, cancer risk assessment and education
  2. Cancer screening affiliated with the National Health Screening Program
  3. Health education on cancer and risks
shape1
shape3

Department

icon

Department


Key Activities

icon

THE BRUNEI CANCER CENTRE (TBCC)

  • Offers multi-technology molecular profiling of the cancer to personalize cancer treatment; and a centre of excellence and coordination for the early detection and prevention of cancer
  • Inpatient Facilities under TBCC
    • Inpatient Cancer Ward
    • Radioiodine Ward
    • Outpatient Facilities

Outpatient Clinic for patients seeking:

  • Medical Oncology consultation and services
  • Early Detection and Cancer Prevention consultation and services
  • Chemo therapy treatment and TBCC Day Ward Facilities
  • Nuclear Medicine consultation and services
  • Radiotherapy consultation and services
  • Dietetics & Medical Social Worker consultation and services

 

 

THE BRUNEI CANCER CENTRE (TBCC)

Medical Oncology Services

  • Personalized targeted therapy
  • Chemotherapy
  • Palliative Care treatment
  • Immunotherapy

Radiation Oncology Services

  • Edge® Radiosurgery System, True Beam ®) Radiotherapy System, CT Simulator
    • Stereotactic Surgery
    • Intensity-Modulated Radiation Therapy, Volumetric Arc Therapy
  • Nuclear Medicine Services
    • Nuclear Diagnostics
      • SPECT-CT, PET-CT
    • Nuclear Therapies
      • Radioiodine Therapy, 1-131 high Dose MIBG Therapy, Bone Palliation Therapy

 

THE BRUNEI CANCER CENTRE (TBCC)

Early Detection & CanceR Prevention Services (EDCPS)

  • Offer screening examinations for healthy individuals and those with high risk families for early  detection   and coordination of their care and referrals to the tertiary centre
  • Early Detection by assessing and evaluating those with symptoms /signs and risk factors
  • Providing comprehensive guidance on diet and physical activities for reduction of cancer risks in the healthy individuals. 
  • Managing risks of developing cancer through periodic monitoring, counselling and educational programmes

 

Key Research

icon
  • Survival Rates and Associated Factors of Colorectal Cancer Patients in Brunei Darussalam. Leong E, Ong SK, Madli F, Tan A, Lai D, Basir N, Ramlee N, Chong VH. Asian Pac J Cancer Prev. 2020 Jan 1;21(1):259-265. doi: 10.31557/APJCP.2020.21.1.259.
  • Childhood Cancer Survival in Brunei Darussalam. Leong E, Ong SK, Jali F, Ramlee N. Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3259-3266. doi: 10.31557/APJCP.2020.21.11.3259.
  • Fluorescence in situ hybridisation analysis of human epidermal growth factor receptor 2 status for breast cancer cases in Brunei Darussalam. Kok JPC, Haji Abdul Hamid MRW, Patnaik RS, Kok KYY. Cancer Rep (Hoboken). 2020 Oct;3(5):e1249. doi: 10.1002/cnr2.1249. Epub 2020 Jun 8.
  • The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres. Gatellier L, Shankar A, Dewi LKM, Hussain QM, Dendup Wangdi T, Sukumaran DB, et al. Asian Pac J Cancer Prev. 2021 Mar 1;22(3):681-690. doi: 10.31557/APJCP.2021.22.3.681. PMID: 33773529.
  • Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer. Ishak NS, Abdul Rahman H, Lee SHF, Lu SK, Naing L. J Gastrointest Cancer. 2021 Jan 4. doi: 10.1007/s12029-020-00559-w. Epub ahead of print. PMID: 33392958.

Cancer Profile

icon
No Data
shape1
shape2

Stay connect with us

icon

Please complete the form below to send us an E-Mail. For security and anti-spam purposes, we do not post our E-Mail addresses on our website.